Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9034 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.902 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8973 |
High Similarity |
NPD1549 |
Phase 2 |
0.8954 |
High Similarity |
NPD1934 |
Approved |
0.8896 |
High Similarity |
NPD7819 |
Suspended |
0.8896 |
High Similarity |
NPD2801 |
Approved |
0.8867 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8797 |
High Similarity |
NPD6959 |
Discontinued |
0.8718 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8707 |
High Similarity |
NPD2796 |
Approved |
0.8701 |
High Similarity |
NPD4380 |
Phase 2 |
0.8639 |
High Similarity |
NPD1510 |
Phase 2 |
0.8634 |
High Similarity |
NPD6166 |
Phase 2 |
0.8634 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD5494 |
Approved |
0.8608 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD1511 |
Approved |
0.8493 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8491 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8467 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8428 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8424 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8418 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8408 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8383 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8377 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8377 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8377 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8377 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8375 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8365 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8364 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8355 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8313 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8253 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.825 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8166 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8113 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8092 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8086 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8039 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8026 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7922 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7852 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7849 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7844 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7812 |
Intermediate Similarity |
NPD920 |
Approved |
0.7799 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7792 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7763 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7763 |
Intermediate Similarity |
NPD943 |
Approved |
0.7763 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7709 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7701 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7688 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7632 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7596 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD37 |
Approved |
0.7574 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7545 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7545 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7527 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1201 |
Approved |
0.75 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7456 |
Intermediate Similarity |
NPD919 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7418 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7377 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7372 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7372 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7356 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7333 |
Intermediate Similarity |
NPD9717 |
Approved |
0.733 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7318 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7801 |
Approved |
0.729 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7267 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD17 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7195
|
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |